Bimekizumab impact on draining tunnels: A dynamic assessment in patients with moderate to severe HS using pooled Week 48 results from BE HEARD I&II. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s475. https://doi.org/10.25251/skin.8.supp.475